Clinical trial Recruiting at 1 site Observational Ages 65 to 80 Women only

Immunonutrition and Brain Monitoring to See if Delirium Happens After Gynecologic Cancer Surgery

Official title: Predictive Value of Preoperative CONUT and Naples Prognostic Scores Combined With Intraoperative Neuromonitoring for Early Postoperative Delirium in Elderly Patients Undergoing Gynecologic Oncological Surgery: A Prospective Study

Run by Elazıg Fethi Sekin Sehir Hastanesi · NCT07877285 · Data updated 2026-11-12

This study tests whether a preoperative immunonutrition scoring plus intraoperative brain monitoring can help predict or relate to postoperative delirium in women aged 65 and older undergoing major gynecologic cancer surgery.

More Gynecologic Cancers trials

Quick facts

Study typeObservational
Ages65 Years to 80 Years
SexWomen only
Enrollment80 (estimated)
SponsorElazıg Fethi Sekin Sehir Hastanesi
Academic / other
Locations1 site (Elâzığ, Elâzığ)
StatusRecruiting
StartedOctober 1, 2026
Main results expectedJanuary 1, 2027
Study endsFebruary 1, 2027
Registry record updatedOctober 16, 2026
Trial IDNCT07877285 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 65 years and older scheduled for elective major gynecologic oncologic surgery under general anesthesia with intraoperative neuromonitoring.

Probably not a fit

Patients without postoperative delirium or whose delirium risk is unrelated to nutritional or neuromonitoring factors may not experience direct benefit from these findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational cohort study enrolls women aged 65+ scheduled for elective major gynecologic oncologic procedures under general anesthesia with intraoperative neuromonitoring. It examines whether preoperative immunonutrition scores (CONUT) and Naples Prognostic Score, combined with real-time intraoperative cerebral depth monitoring, relate to the occurrence of postoperative delirium. Data collected include preoperative nutritional and inflammatory markers, intraoperative neuromonitoring metrics, and postoperative delirium assessments. The goal is to improve understanding of how nutritional status and brain monitoring may predict or correlate with POD in this high-risk population. The study is conducted at Elazığ City Hospital under local leadership, with no stated randomization or intervention beyond observation.

Why it matters

Potential benefit: If successful, findings could improve risk stratification and guide perioperative care to reduce delirium in elderly gynecologic cancer patients.

How similar studies have gone: Previous work has linked nutrition and inflammation to surgical outcomes, but this study explores a novel combination with intraoperative neuromonitoring in gynecologic oncology.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Female patients aged 65 years or older.
2. Scheduled for elective major gynecologic oncological surgery (e.g., radical hysterectomy, cytoreductive surgery for ovarian, cervical, or endometrial cancer).
3. American Society of Anesthesiologists (ASA) physical status II-IV.
4. Planned to undergo general anesthesia with continuous intraoperative neuromonitoring / processed EEG.
5. Signed written informed consent provided prior to surgery.

Exclusion Criteria:

1. Pre-existing dementia, significant cognitive impairment, or baseline Mini-Mental State Examination (MMSE) score below validated cut-offs.
2. History of major neuropsychiatric disorders, active neurodegenerative disease, or acute cerebrovascular accident within the preceding 6 months.
3. Patients undergoing emergency surgical procedures.
4. Uncorrected severe sensory deficits (auditory or visual impairments) precluding postoperative delirium assessments.
5. Missing preoperative baseline nutritional or hematological laboratory parameters required for CONUT or Naples scoring.
6. Inability to comply with post-anesthesia cognitive evaluations or re-operation required during the observation window.

Where it's running

  • Fethi Sekin City Hospital
    Elâzığ, Elâzığ, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Muhammed BaŞpınar, M.D. — Elazıg Fethi Sekin Sehir Hastanesi
  • Study coordinator: Muhammed Başpınar, M.D. / Specialist
  • Email: bspnr.muhammed@gmail.com
  • Phone: +90 539 583 11 41

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.